C33H35N2NaO8 — CID 23705838
sodium (E)-2-(2,1,3-benzoxadiazol-5-yl)-4-(4-methoxyphenyl)-4-oxo-3-[[3,4,5-tri(propan-2-yloxy)phenyl]methyl]but-2-enoate (PubChem CID 23705838) has the molecular formula C33H35N2NaO8 and a molecular weight of 610.64 g/mol. Its IUPAC name is sodium (E)-2-(2,1,3-benzoxadiazol-5-yl)-4-(4-methoxyphenyl)-4-oxo-3-[[3,4,5-tri(propan-2-yloxy)phenyl]methyl]but-2-enoate.
| Compound Name | sodium (E)-2-(2,1,3-benzoxadiazol-5-yl)-4-(4-methoxyphenyl)-4-oxo-3-[[3,4,5-tri(propan-2-yloxy)phenyl]methyl]but-2-enoate |
|---|---|
| PubChem CID | 23705838 |
| Molecular Formula | C33H35N2NaO8 |
| Molecular Weight | 610.64 g/mol |
| Exact Mass | 610.23 |
| IUPAC Name | sodium (E)-2-(2,1,3-benzoxadiazol-5-yl)-4-(4-methoxyphenyl)-4-oxo-3-[[3,4,5-tri(propan-2-yloxy)phenyl]methyl]but-2-enoate |
| SMILES | COc1ccc(C(=O)/C(Cc2cc(OC(C)C)c(OC(C)C)c(OC(C)C)c2)=C(/C(=O)[O-])c2ccc3nonc3c2)cc1.[Na+] |
| InChI | InChI=1S/C33H36N2O8.Na/c1-18(2)40-28-15-21(16-29(41-19(3)4)32(28)42-20(5)6)14-25(31(36)22-8-11-24(39-7)12-9-22)30(33(37)38)23-10-13-26-27(17-23)35-43-34-26;/h8-13,15-20H,14H2,1-7H3,(H,37,38);/q;+1/p-1/b30-25+; |
| InChIKey | DQJGYHNVNNVZSR-KEDMHLQRSA-M |
| XLogP | 2.23 |
| TPSA | 133.04 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 44 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 610.64 |
| LogP ≤ 5 | 2.23 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 10 |
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|